<DOC>
	<DOCNO>NCT02923206</DOCNO>
	<brief_summary>This clinical investigation medical device trial examine safety efficacy TheraSorb sFlt-1 adsorber treatment pregnant patient preeclampsia .</brief_summary>
	<brief_title>Proof-of-Concept Trial Selective Removal sFlt-1 Pregnant Women With Preeclampsia Via Apheresis</brief_title>
	<detailed_description />
	<mesh_term>Pre-Eclampsia</mesh_term>
	<criteria>Reduced criterion ! Phase 0 Age ≥18 ≤45 year ; Male female ; Female subject childbearing potential must negative serum pregnancy test result screen practice two reliable method contraception throughout study . Dysfunction cerebral nervous system and/or heart disease ; History preexist chronic renal disease ; Treatment ACE inhibitor ; Therapeutic full anticoagulation therapy prior trial entry ; Liver abnormalities ; Clinically significant pulmonary edema and/or thrombocytopenia and/or anemia ; Active hepatitis B , C , tuberculosis infection HIV infection Hypersensitivity heparin and/or citrate ; Indications prohibit transient anticoagulation use heparin and/or ACDAsolutions ; Known intolerance extracorporeal procedures general towards one individual excipients towards support agent ; Drug alcohol abuse within last 2 year ; Lack compliance subject ; History diagnosis severe periodontitis ; Phase A B Age &gt; 18 ≤45 year ; Pregnant woman preterm preeclampsia sFlt1/PlGF ratio ≥85 ; sFlt1 level ≥ 8000pg/mL Maternal exclusion criterion History cardiac impairment include uncontrolled arrhythmia , unstable angina , decompensated congestive heart failure valve disease ; History preexist chronic renal disease and/ preexist clinically significant proteinuria , prior pregnancy ; Treatment ACE inhibitors/ reninangiotensinsystem blocker ; Therapeutic full anticoagulation therapy prior trial entry ; Signs history clinically significant cerebral nervous system dysfunction ; History clinically significant liver abnormality ; Clinically significant pulmonary edema and/or thrombocytopenia and/or anemia ; Active hepatitis B , C , tuberculosis infection HIV infection ; Any condition investigator deem risk patient fetus complete trial ; Indications prohibit transient anticoagulation use heparin and/or ACDAsolutions ; Drug alcohol abuse within last 2 year ; Lack compliance patient ; Known intolerance extracorporeal procedures general one excipients support agent ; Hypersensitivity heparin and/or citrate ; Evidence `` reverse zero Doppler '' flow umbilical Doppler ; Various Placental exclusion criterion ; Multiple pregnancy History diagnosis severe periodontitis Various fetal exclusion criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>apheresis</keyword>
	<keyword>pregnancy</keyword>
	<keyword>pre-eclampsia</keyword>
	<keyword>PE</keyword>
	<keyword>sFlt-1</keyword>
	<keyword>Pre-term</keyword>
</DOC>